体格制限のある小児や，特有の心臓構造を持つ先天性心疾患ではリードや植込み法の選択のみならず，その自然歴を勘案したデバイス治療が重要である．また，新しい機能，ペーシングデバイスも登場しており，同領域での植込み数の増加が予想される．本稿では，小児・先天性心疾患のデバイス治療の最近の知見について述べる．
In children with size limitations and congenital heart disease with unique cardiac structures, selection of the lead and implantation method and provision of device therapy that considers the natural history are both important. New functional and pacing devices are emerging, and the number of implantations for these condition is expected to increase. This paper described recent clinical findings on device therapy for pediatric and congenital heart disease.
Key words: pacemaker; cardiac resynchronization therapy; implantable cardioverter defibrillator; child and adolescence; congenital heart disease
© 2024 特定非営利活動法人日本小児循環器学会© 2024 Japanese Society of Pediatric Cardiology and Cardiac Surgery
This page was created on 2024-07-10T11:46:29.529+09:00
This page was last modified on 2024-08-14T13:12:35.000+09:00
このサイトは（株）国際文献社によって運用されています。
